Asia Pacific Male Infertility Market By Treatment (Assisted Reproductive Technology & Varicocele Surgery and Medication), By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests), By Country, Industry Analysis and Forecast, 2020 - 2026
The Asia Pacific Male Infertility Market would witness market growth of 8.9% CAGR during the forecast period (2020-2026).
One of the key causes causing male infertility is sperm heterogeneity of DNA. Male infertility is a heterogeneous group of disorders, known causes account for only 30-50 percent, and unknown cause (idiopathic) is the rest. Infertility affects about 15 percent of people of reproductive age, and the male problem alone involves about 40 percent of the problems.
Tobacco smoke contains approximately 4,000 compounds, like alkaloids, nitrosamines, and inorganic molecules, and some of these are reactive oxygen or nitrogen species. A positive and significant association has been identified between active smoking and sperm DNA fragmentation and also axonemal damage. Smoking is often associated with a decreased sperm count. Smoking is considered to enhance spermatogenesis by increasing the production of norepinephrine, which increases the conversion of testosterone to estrogen causing decreased testosterone levels.
Sperm agglutination refers to the amount of sperm stuck together in the sample given. When evaluating a fertility test result, the percentage assigned to sperm agglutination is the percentage of sperm stuck together in the sample. For example, if the semen sample had only half the sperm sticking together, the report would read only 50 percent sperm agglutination.
Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.
Scope of the Study
Market Segmentation:
By Treatment
One of the key causes causing male infertility is sperm heterogeneity of DNA. Male infertility is a heterogeneous group of disorders, known causes account for only 30-50 percent, and unknown cause (idiopathic) is the rest. Infertility affects about 15 percent of people of reproductive age, and the male problem alone involves about 40 percent of the problems.
Tobacco smoke contains approximately 4,000 compounds, like alkaloids, nitrosamines, and inorganic molecules, and some of these are reactive oxygen or nitrogen species. A positive and significant association has been identified between active smoking and sperm DNA fragmentation and also axonemal damage. Smoking is often associated with a decreased sperm count. Smoking is considered to enhance spermatogenesis by increasing the production of norepinephrine, which increases the conversion of testosterone to estrogen causing decreased testosterone levels.
Sperm agglutination refers to the amount of sperm stuck together in the sample given. When evaluating a fertility test result, the percentage assigned to sperm agglutination is the percentage of sperm stuck together in the sample. For example, if the semen sample had only half the sperm sticking together, the report would read only 50 percent sperm agglutination.
Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.
Scope of the Study
Market Segmentation:
By Treatment
- Assisted Reproductive Technology & Varicocele Surgery and
- Medication
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Computer Assisted Semen Analysis
- Microscopic Examination
- Sperm Agglutination
- Sperm Penetration Assay and
- Other Tests
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- Sanofi S.A.
- Bayer AG
- Cadila Healthcare Ltd. (Zydus Cadila)
- Endo International PLC
- Aytu BioScience, Inc.
- Vitrolife AB
- SCSA Diagnostics, Inc.
- Andrology Solutions Limited
- Halotech DNA SL
- Intas Pharmaceutical Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Male Infertility Market, by Treatment
1.4.2 Asia Pacific Male Infertility Market, by Tests
1.4.3 Asia Pacific Male Infertility Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT
3.1 Asia Pacific Assisted Reproductive Technology and Varicocele Surgery Market by Country
3.2 Asia Pacific Medication Market by Country
CHAPTER 4. ASIA PACIFIC MALE INFERTILITY MARKET BY TEST
4.1 Asia Pacific DNA Fragmentation Technique Market by Country
4.2 Asia Pacific Oxidative Stress Analysis Market by Country
4.3 Asia Pacific Computer Assisted Semen Analysis Market by Country
4.4 Asia Pacific Microscopic Examination Market by Country
4.5 Asia Pacific Sperm Agglutination Market by Country
4.6 Asia Pacific Sperm Penetration Assay Market by Country
4.7 Asia Pacific Other Test Market by Country
CHAPTER 5. ASIA PACIFIC MALE INFERTILITY MARKET BY COUNTRY
5.1 India Male Infertility Market
5.1.1 India Male Infertility Market by Treatment
5.1.2 India Male Infertility Market by Test
5.2 China Male Infertility Market
5.2.1 China Male Infertility Market by Treatment
5.2.2 China Male Infertility Market by Test
5.3 Japan Male Infertility Market
5.3.1 Japan Male Infertility Market by Treatment
5.3.2 Japan Male Infertility Market by Test
5.4 South Korea Male Infertility Market
5.4.1 South Korea Male Infertility Market by Treatment
5.4.2 South Korea Male Infertility Market by Test
5.5 Singapore Male Infertility Market
5.5.1 Singapore Male Infertility Market by Treatment
5.5.2 Singapore Male Infertility Market by Test
5.6 Malaysia Male Infertility Market
5.6.1 Malaysia Male Infertility Market by Treatment
5.6.2 Malaysia Male Infertility Market by Test
5.7 Rest of Asia Pacific Male Infertility Market
5.7.1 Rest of Asia Pacific Male Infertility Market by Treatment
5.7.2 Rest of Asia Pacific Male Infertility Market by Test
CHAPTER 6. COMPANY PROFILES
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Male Infertility Market, by Treatment
1.4.2 Asia Pacific Male Infertility Market, by Tests
1.4.3 Asia Pacific Male Infertility Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT
3.1 Asia Pacific Assisted Reproductive Technology and Varicocele Surgery Market by Country
3.2 Asia Pacific Medication Market by Country
CHAPTER 4. ASIA PACIFIC MALE INFERTILITY MARKET BY TEST
4.1 Asia Pacific DNA Fragmentation Technique Market by Country
4.2 Asia Pacific Oxidative Stress Analysis Market by Country
4.3 Asia Pacific Computer Assisted Semen Analysis Market by Country
4.4 Asia Pacific Microscopic Examination Market by Country
4.5 Asia Pacific Sperm Agglutination Market by Country
4.6 Asia Pacific Sperm Penetration Assay Market by Country
4.7 Asia Pacific Other Test Market by Country
CHAPTER 5. ASIA PACIFIC MALE INFERTILITY MARKET BY COUNTRY
5.1 India Male Infertility Market
5.1.1 India Male Infertility Market by Treatment
5.1.2 India Male Infertility Market by Test
5.2 China Male Infertility Market
5.2.1 China Male Infertility Market by Treatment
5.2.2 China Male Infertility Market by Test
5.3 Japan Male Infertility Market
5.3.1 Japan Male Infertility Market by Treatment
5.3.2 Japan Male Infertility Market by Test
5.4 South Korea Male Infertility Market
5.4.1 South Korea Male Infertility Market by Treatment
5.4.2 South Korea Male Infertility Market by Test
5.5 Singapore Male Infertility Market
5.5.1 Singapore Male Infertility Market by Treatment
5.5.2 Singapore Male Infertility Market by Test
5.6 Malaysia Male Infertility Market
5.6.1 Malaysia Male Infertility Market by Treatment
5.6.2 Malaysia Male Infertility Market by Test
5.7 Rest of Asia Pacific Male Infertility Market
5.7.1 Rest of Asia Pacific Male Infertility Market by Treatment
5.7.2 Rest of Asia Pacific Male Infertility Market by Test
CHAPTER 6. COMPANY PROFILES
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 ASIA PACIFIC MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 3 ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 4 ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 5 ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 ASIA PACIFIC MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 ASIA PACIFIC SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 ASIA PACIFIC SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 ASIA PACIFIC SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 ASIA PACIFIC SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 ASIA PACIFIC OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 ASIA PACIFIC OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 ASIA PACIFIC MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 ASIA PACIFIC MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 INDIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 28 INDIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 29 INDIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 30 INDIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 31 INDIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 32 INDIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 33 CHINA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 34 CHINA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 35 CHINA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 36 CHINA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 37 CHINA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 38 CHINA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 39 JAPAN MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 40 JAPAN MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 41 JAPAN MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 42 JAPAN MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 43 JAPAN MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 44 JAPAN MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 45 SOUTH KOREA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SOUTH KOREA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SOUTH KOREA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 48 SOUTH KOREA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 49 SOUTH KOREA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 50 SOUTH KOREA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 51 SINGAPORE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 52 SINGAPORE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 53 SINGAPORE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 54 SINGAPORE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 55 SINGAPORE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 56 SINGAPORE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 57 MALAYSIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 58 MALAYSIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 59 MALAYSIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 60 MALAYSIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 61 MALAYSIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 62 MALAYSIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 63 REST OF ASIA PACIFIC MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 64 REST OF ASIA PACIFIC MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 65 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 66 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 67 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 68 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 69 KEY INFORMATION – SANOFI S.A.
TABLE 70 KEY INFORMATION – BAYER AG
TABLE 71 KEY INFORMATION – CADILA HEALTHCARE LTD.
TABLE 72 KEY INFORMATION – ENDO INTERNATIONAL PLC
TABLE 73 KEY INFORMATION – AYTU BIOSCIENCE, INC.
TABLE 74 KEY INFORMATION – VITROLIFE AB
TABLE 75 KEY INFORMATION – SCSA DIAGNOSTICS, INC.
TABLE 76 KEY INFORMATION – ANDROLOGY SOLUTIONS LIMITED
TABLE 77 KEY INFORMATION – HALOTECH DNA SL
TABLE 78 KEY INFORMATION – INTAS PHARMACEUTICAL LTD.
TABLE 1 ASIA PACIFIC MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 3 ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 4 ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 5 ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 ASIA PACIFIC MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 ASIA PACIFIC SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 ASIA PACIFIC SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 ASIA PACIFIC SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 ASIA PACIFIC SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 ASIA PACIFIC OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 ASIA PACIFIC OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 ASIA PACIFIC MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 ASIA PACIFIC MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 INDIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 28 INDIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 29 INDIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 30 INDIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 31 INDIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 32 INDIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 33 CHINA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 34 CHINA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 35 CHINA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 36 CHINA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 37 CHINA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 38 CHINA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 39 JAPAN MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 40 JAPAN MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 41 JAPAN MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 42 JAPAN MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 43 JAPAN MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 44 JAPAN MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 45 SOUTH KOREA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SOUTH KOREA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SOUTH KOREA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 48 SOUTH KOREA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 49 SOUTH KOREA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 50 SOUTH KOREA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 51 SINGAPORE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 52 SINGAPORE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 53 SINGAPORE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 54 SINGAPORE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 55 SINGAPORE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 56 SINGAPORE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 57 MALAYSIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 58 MALAYSIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 59 MALAYSIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 60 MALAYSIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 61 MALAYSIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 62 MALAYSIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 63 REST OF ASIA PACIFIC MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 64 REST OF ASIA PACIFIC MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 65 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 66 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 67 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 68 REST OF ASIA PACIFIC MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 69 KEY INFORMATION – SANOFI S.A.
TABLE 70 KEY INFORMATION – BAYER AG
TABLE 71 KEY INFORMATION – CADILA HEALTHCARE LTD.
TABLE 72 KEY INFORMATION – ENDO INTERNATIONAL PLC
TABLE 73 KEY INFORMATION – AYTU BIOSCIENCE, INC.
TABLE 74 KEY INFORMATION – VITROLIFE AB
TABLE 75 KEY INFORMATION – SCSA DIAGNOSTICS, INC.
TABLE 76 KEY INFORMATION – ANDROLOGY SOLUTIONS LIMITED
TABLE 77 KEY INFORMATION – HALOTECH DNA SL
TABLE 78 KEY INFORMATION – INTAS PHARMACEUTICAL LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
